A retrospective clinical study: combined treatment of chemotherapy and radiotherapy results in optimal outcome for limited-stage extranodal NK/T-cell lymphoma

被引:0
|
作者
Zheng, Yan-Bin [1 ,2 ,3 ]
Yang, Yu [1 ,2 ,3 ]
Lin, Jian-Yang [1 ,2 ,3 ]
Wang, Jie-Song [1 ,2 ,3 ]
Wu, Hui [1 ,2 ,3 ]
Chen, Ying [1 ,2 ,3 ]
Chen, Dao-Guang [1 ,2 ,3 ]
Chen, Ning-Bin [1 ,2 ,3 ]
Zou, Si-Ping [1 ,2 ,3 ]
Chen, Xiu-Rong [1 ,2 ,3 ]
He, Hong-Ming [1 ,2 ,3 ]
机构
[1] Fujian Canc Hosp, Dept Lymphoma, Fuzhou 350014, Fujian, Peoples R China
[2] Fujian Med Univ, Canc Hosp, Fuzhou 350014, Fujian, Peoples R China
[3] Fujian Key Lab Translat Canc Med, Fuzhou 350014, Fujian, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2018年 / 11卷 / 04期
关键词
Extranodal NK/T-cell lymphoma; treatment; prognostic factor; retrospective analysis; NATURAL KILLER/T-CELL; PERIPHERAL T-CELL; NASAL-TYPE; PROGNOSTIC-FACTORS; MULTICENTER; RADIATION; SURVIVAL; THERAPY; FAILURE; IIE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Extranodal NK/T-cell lymphoma (ENKL) is an aggressive lymphoma with higher prevalence in Asia. Optimal therapeutic strategies for early-stage ENKL remain controversial. Here, we report a retrospective clinical study with 137 patients to assess the prognostic factors and optimal treatment for localized ENKL. The 5-year overall survival (OS) and progression-free survival (PFS) were 54.7% and 48.2%, respectively. Patients were grouped by the therapies received: chemotherapy alone (CT, n = 16), radiotherapy alone (RT, n = 24), and combined modality therapy (CMT, n = 97). Compared with the patients who received CT or RT alone, the patients who received CMT had more favourable OS outcomes (5-year OS, CMT: 66.9% vs. RT: 40.4% vs. CT: 0%, P<0.001). A multivariate analysis identified disease stage, lactate dehydrogenase levels and treatment strategy as prognostic factors that influenced PFS and OS. In the CMT subgroups, patients who received CT followed by RT (CRT) exhibited longer survival than patients who received RT followed by CT (RCT). In conclusion, for early-stage ENKL, CMT is the treatment modality that will most likely lead to long-term remission.
引用
收藏
页码:3235 / 3244
页数:10
相关论文
共 50 条
  • [41] Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL1008)
    Yoon, Dok Hyun
    Kim, Seok Jin
    Jeong, Seong Hyun
    Shin, Dong-Yeop
    Bae, Sung Hwa
    Hong, Junshik
    Park, Seong Kyu
    Yhim, Ho-Young
    Yang, Deok-Hwan
    Lee, Hyewon
    Kang, Hye Jin
    Lee, Mark Hong
    Eom, Hyeon-Seok
    Kwak, Jae-Yong
    Lee, Jae Hoon
    Suh, Cheolwon
    Kim, Won Seog
    ONCOTARGET, 2016, 7 (51): : 85584 - 85591
  • [42] Long-term survival by surgery and adjuvant chemotherapy in a patient with perforated extranodal NK/T-cell lymphoma of the small intestine: a retrospective case study
    Hiroshi Funaki
    Naomi Nojima
    Yutaka Takikawa
    Kazutoshi Komori
    Hajime Hasegawa
    Tomoyuki Sakai
    Sohsuke Yamada
    Yasufumi Masaki
    Surgical Case Reports, 9
  • [43] The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma
    Song, Yuzhi
    Li, Jing
    Wang, Shuoshuo
    Zhou, Zhiguo
    Qiao, Xueying
    Zhao, Xinming
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 2907 - 2914
  • [44] RADIOTHERAPY ALONE WITH CURATIVE INTENT IN PATIENTS WITH STAGE I EXTRANODAL NASAL-TYPE NK/T-CELL LYMPHOMA
    Li, Ye-Xiong
    Wang, Hua
    Jin, Jing
    Wang, Wei-Hu
    Liu, Qing-Feng
    Song, Yong-Wen
    Wang, Zhao-Yang
    Qi, Shu-Nan
    Wang, Shu-Lian
    Liu, Yue-Ping
    Liu, Xin-Fan
    Yu, Zi-Hao
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : 1809 - 1815
  • [45] PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity
    Zheng, Wen
    Gao, Yuhuan
    Ke, Xiaoyan
    Zhang, Weijing
    Su, Liping
    Ren, Hanyun
    Lin, Ningjing
    Xie, Yan
    Tu, Meifeng
    Liu, Weiping
    Ping, Lingyan
    Ying, Zhitao
    Zhang, Chen
    Deng, Lijuan
    Wang, Xiaopei
    Song, Yuqin
    Zhu, Jun
    BMC CANCER, 2018, 18
  • [46] Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma
    Wang, Z. Y.
    Li, Y. X.
    Wang, H.
    Wang, W. H.
    Jin, J.
    Liu, Y. P.
    Song, Y. W.
    Wang, S. L.
    Liu, X. F.
    Yu, Z. H.
    ANNALS OF ONCOLOGY, 2011, 22 (02) : 390 - 396
  • [47] Chemotherapy combined with high-dose extended-field radiotherapy for stage I extranodal nasal-type natural killer/T-cell lymphoma
    Luo, Jialin
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Zhang, Na
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6147 - 6150
  • [48] Addition of Chidamide to a Sandwich Protocol, Pegaspargase, Gemcitabine and Oxaliplatin Chemotherapy Combined with Radiotherapy, As First-Line Treatment in Early Stage NK/T-Cell Lymphoma: Real World Outcomes in a Retrospective Study
    Xia, Fan
    Ping, Nana
    Bao, Qi
    Zou, Rui
    Zhu, Qian
    Zhang, Xiao
    Wu, Depei
    Jin, Zhengming
    Qu, Changju
    BLOOD, 2023, 142
  • [49] Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/IINK/T-cell lymphoma
    Kwong, Y. L.
    Kim, S. J.
    Tse, E.
    Oh, S. Y.
    Kwak, J. Y.
    Eom, H. S.
    Do, Y. R.
    Mun, Y. C.
    Lee, S. R.
    Shin, H. J.
    Suh, C.
    Chuang, S. S.
    Lee, Y. S.
    Lim, S. T.
    Izutsu, K.
    Suzuki, R.
    Relander, T.
    d'Amore, F.
    Schmitz, N.
    Jaccard, A.
    Kim, W. S.
    ANNALS OF ONCOLOGY, 2018, 29 (01) : 256 - 263
  • [50] Chemotherapy combined with radiotherapy for successful treatment of angioimmunoblastic T-cell lymphoma: a case report
    Xiong, Yudi
    Yang, Lei
    Dai, Jing
    Zhou, Fuxiang
    Zhou, Yunfeng
    JOURNAL OF MEDICAL CASE REPORTS, 2020, 14 (01)